3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Further Experience with Antihuman Lymphocyte Globulin (Behring): No Effect on Cadaveric Renal Graft Survival

, , , , &
Pages 295-297 | Received 18 Dec 1980, Published online: 15 Feb 2010

REFERENCES

  • Groth, C. G., Berg, B., Collste, H., Lundgren, G., Magnusson. G., Ringdén, O. & Pieper, R. 1977. A controlled trial of anti-human lymphocyte globulin (Behring) in cadaveric renal transplantation: Improvement in graft and patient survival at one year using a high-dose regimen. Scand J Urol Nephrol, Suppl. 42: 83.
  • Seiler, F. R. 1976. Development, production and quality control of clinically applied antilymphocyte globulin. Postgrad Med J 52, Suppl. 5, 11.
  • Uittenbogaart, C. H., Robinson, B. J., Malekzadeh, M. H., Pennisi, A. J., Ettenger, R. B. & Fine, R. N. 1979. Use of antithymocyte globulin (dose by rosette protocol) in pediatric renal allograft recipients. Transplantation, 28 (4), 291.
  • Wechter, W. J., Brodie, J. A., Morell, R. M., Rafi, M. & Schultz, J. R. 1979. Antithymocyte globulin (ATGAM) in renal allograft recipients. Transplantation, 28 (4), 294.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.